L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study
This randomized controlled trial examined the effects of intravenous L-carnitine supplementation on fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome. Participants receiving 4 g/day of intravenous L-carnitine experienced significantly greater weight loss (-4.6 ± 0.9 kg vs. -3.2 ± 1.1 kg, P = 0.03), reductions in waist
June 26, 2025
No Comments